Phibro Animal Health (PAHC) Tops Q4 EPS by 6c; Guides FY16 EPS Below Expectations

Phibro Animal Health (NASDAQ: PAHC) reported Q4 EPS of $0.44, $0.06 better than the analyst estimate of $0.38. Revenue for the quarter came in at $185 million versus the consensus estimate of $188.51 million.

Phibro Animal Health sees FY2016 EPS of $1.65-$1.75, versus the consensus of $1.77. Phibro Animal Health sees FY2016 revenue of $780-800 million, versus the consensus of $792.3 million.

For earnings history and earnings-related data on Phibro Animal Health (PAHC) click here.

You May Also Be Interested In

• Korn Ferry (KFY) Tops Q4 EPS by 2c, Beats on Revenue; Offers Q1 Guidance
• AMC Entertainment prices $200M stock offering to redeem senior notes
• Amylyx ALS drug shows no serious adverse events in Phase 1 trial